This resource is no longer available

The life sciences industry is digitally evolving with DTC telehealth. This paper examines DTC strategies by pharma and health companies.

Key points:
• Pharma's DTC telehealth investments address clinician shortages, access, education, and adherence.
• Virtual care aims to improve satisfaction, loyalty, and market standing.
• Main DTC models: immediate doctor access and OTC medication virtual pathways.
• Telehealth empowers patients, fosters trust, and tackles healthcare gaps.

Despite its promise, telehealth must overcome regulatory, security, and reimbursement challenges. The full white paper details telehealth's potential in life sciences.